Open Letter Calling for Urgent High-Level US Leadership to Address Escalating Global COVID-19 Vaccine Crisis csis.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from csis.org Daily Mail and Mail on Sunday newspapers.
email.
Last week, an advisory committee to the US Centers for Disease Control and Prevention (CDC) recommended that Pfizer’s COVID-19 vaccine be offered to adolescents between the ages of 12 and 15, following the vaccine’s authorization for this age group by the US Food and Drug Administration earlier in the week. CDC Director Rochelle Walensky adopted the recommendation later Wednesday, clearing the way for vaccine clinics to begin to vaccinate 12-to-15-year-olds. The recommendation was based on data indicating the vaccine was protective for this age group; in a trial of 2,260 adolescents, there were 18 confirmed cases of COVID-19 among those who received a placebo and no confirmed cases among those who received the vaccine.
Both Democrats and Republicans questioned the waiver…
IP is the lifeblood of American innovation,
said Rep. Stephanie Murphy (D-FL). She requested consideration of other courses of action to improve distribution while allowing manufacturers to maintain control of IP.
Handing over U.S. technology won’t help the pandemic. Development of facilities, workforce, and distribution takes years, said
Ways & Means Ranking Member Kevin Brady (R-TX).
Rep. Drew Ferguson (R-GA) agreed, questioning other countries’ resources and quality standards.
Senate Finance Ranking Member Mike Crapo (R-ID) said the waiver would undermine progress in ending the pandemic, noting that Bill Gates says it will not advance vaccine distribution, while Vladimir Putin supports the waiver.
Open Letter to the Biden Administration and US Congress Calling for Urgent High-Level US Leadership to Address Escalating Global COVID-19 Vaccine Crisis csis.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from csis.org Daily Mail and Mail on Sunday newspapers.
European Medicines Agency experts beginning Sputnik V manufacturing inspections: Official ANI | Updated: May 12, 2021 19:52 IST
Moscow [Russia], May 12 (ANI/Sputnik): Experts from the European Medicines Agency (EMA) are beginning Russia s Sputnik V COVID-19 vaccine manufacturing inspections, as they have already completed the study of clinical trials, the results of both sets of the inspections will be integrated into the ongoing assessment process, Fergus Sweeney, the head of the EMA s Clinical Studies and Manufacturing Task Force, said on Wednesday. The good clinical practice inspections of the Sputnik clinical trials in Russia have recently completed. EU inspectors are just commencing the good manufacturing practice inspections. The results of both of these sets of inspections are then integrated into the assessment process as it goes on, Sweeney said at a press briefing. (ANI/Sputnik)